Bessemer Group’s Erasca ERAS Stock Holding History

Bessemer Group’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29K	Hold	1,587	–	–	﹤0.01%	1861
2026 Q1	$26K	Hold	1,587	–	–	﹤0.01%	1855
2025 Q4	$6K	Buy	+1,587	New	+$4.46K	﹤0.01%	2218

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bessemer Group's ERAS Position: Q2 2026 in Review

Bessemer Group held its Erasca (ERAS) position steady in Q2 2026 at 1,587 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Bessemer Group first reported a position in ERAS in Q4 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

Bessemer Group held 1,587 shares of Erasca worth $29K as of Q2 2026.
Bessemer Group left its Erasca share count unchanged in Q2 2026.
Erasca made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1861 holding.
Bessemer Group first reported a position in Erasca in Q4 2025 and has held it in 3 quarters since.
257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.